Literature DB >> 29022145

Autoimmune enteropathies.

Sarah E Umetsu1, Ian Brown2, Cord Langner3, Gregory Y Lauwers4.   

Abstract

Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and immune-mediated injury of the intestinal mucosa. As the clinical and histopathologic manifestations of this disease are highly variable, its diagnosis is challenging for both clinicians and pathologists. In fact, the term autoimmune enteropathies is likely more appropriate since the clinicopathologic manifestations are observed in association with a heterogeneous group of disorders. The pathophysiology of AIE has not been fully elucidated. It appears to result from dysregulation of intestinal immunity and particularly in children, often presents in association with immunodeficiency. The overarching histopathologic changes seen in AIE include mucosal inflammation and epithelial injury, although this can manifest in the form of different patterns. Recognition of the clinical settings and of the various histologic patterns can aid the pathologist in establishing the correct diagnosis.

Entities:  

Keywords:  Autoimmune disease; Colitis; Drug induced; Enteritis; Immunodeficiency; Inherited disease

Mesh:

Year:  2017        PMID: 29022145     DOI: 10.1007/s00428-017-2243-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  57 in total

1.  Autoimmune enteropathy and villous atrophy in adults.

Authors:  G R Corazza; F Biagi; U Volta; M L Andreani; L De Franceschi; G Gasbarrini
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

2.  Immunopathogenesis of olmesartan-associated enteropathy.

Authors:  E V Marietta; A M Nadeau; A K Cartee; I Singh; A Rishi; R S Choung; T-T Wu; A Rubio-Tapia; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2015-10-01       Impact factor: 8.171

Review 3.  Epithelia: lymphocyte interactions in the gut.

Authors:  Stephanie Dahan; Franziska Roth-Walter; Paul Arnaboldi; Shradha Agarwal; Lloyd Mayer
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

4.  PD-1 inhibitor gastroenterocolitis: case series and appraisal of 'immunomodulatory gastroenterocolitis'.

Authors:  Raul S Gonzalez; Safia N Salaria; Caitlin D Bohannon; Aaron R Huber; Michael M Feely; Chanjuan Shi
Journal:  Histopathology       Date:  2016-12-20       Impact factor: 5.087

5.  High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives.

Authors:  C Fiocchi; J K Roche; W M Michener
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

6.  Autoantibodies against gut epithelium in child with small-intestinal enteropathy.

Authors:  J A Walker-Smith; D J Unsworth; P Hutchins; A D Phillips; E J Holborow
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

7.  Small intestinal biopsy in cows milk protein allergy in infancy.

Authors:  J L Fontaine; J Navarro
Journal:  Arch Dis Child       Date:  1975-05       Impact factor: 3.791

8.  Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy.

Authors:  Giorgos Bamias; Ioanna Delladetsima; Marina Perdiki; Spyros I Siakavellas; Dimitrios Goukos; George V Papatheodoridis; George L Daikos; Helen Gogas
Journal:  Cancer Invest       Date:  2017-05-26       Impact factor: 2.176

9.  Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Authors:  Clélia Coutzac; Julien Adam; Emilie Soularue; Michael Collins; Antoine Racine; Charlotte Mussini; Lisa Boselli; Nyam Kamsukom; Christine Mateus; Mélinda Charrier; Lydie Cassard; David Planchard; Vincent Ribrag; Karim Fizazi; Yohann Loriot; Patricia Lepage; Jean-Yves Scoazec; Caroline Robert; Franck Carbonnel; Nathalie Chaput
Journal:  J Crohns Colitis       Date:  2017-10-01       Impact factor: 9.071

Review 10.  From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.

Authors:  Rosa Bacchetta; Federica Barzaghi; Maria-Grazia Roncarolo
Journal:  Ann N Y Acad Sci       Date:  2016-02-25       Impact factor: 5.691

View more
  7 in total

Review 1.  [Gastrointestinal tract diseases induced by medications].

Authors:  H Bläker
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

2.  Apoptotic enteropathy, gluten intolerance, and IBD-like inflammation associated with lipotoxicity in DGAT1 deficiency-related diarrhea: a case report of a 17-year-old patient and literature review.

Authors:  Ellen Deolet; Bert Callewaert; Jeroen Geldof; Stephanie Van Biervliet; Saskia Vande Velde; Jo Van Dorpe; Myriam Van Winckel; Anne Hoorens
Journal:  Virchows Arch       Date:  2022-06-28       Impact factor: 4.064

Review 3.  Thymoma-associated multiorgan autoimmunity with exclusive gastrointestinal tract involvement: case report and review of the literature.

Authors:  Tomas Slavik; Fritz M Potgieter; David Brittain
Journal:  Virchows Arch       Date:  2018-01-26       Impact factor: 4.064

Review 4.  [Autoimmune enteropathy in adults : A rare and difficult but relevant differential diagnosis of chronic diarrhea].

Authors:  A Beck; L Schulte; P Möller
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

5.  Consideration of Maternal Anti-enterocyte IgA Transfer With Resulting Infantile Alloimmune Enteropathy.

Authors:  Jennifer B Luginbill; Joe C Rutledge; Matthew J Giefer
Journal:  ACG Case Rep J       Date:  2019-06-14

6.  Epithelial Abnormalities in the Small Intestine of Zambian Children With Stunting.

Authors:  Chola Mulenga; Sanja Sviben; Kanta Chandwe; Beatrice Amadi; Violet Kayamba; James A J Fitzpatrick; Victor Mudenda; Paul Kelly
Journal:  Front Med (Lausanne)       Date:  2022-03-16

7.  Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.

Authors:  Roy L J van Wanrooij; E Andra Neefjes-Borst; Hetty J Bontkes; Marco W J Schreurs; Anton W Langerak; Chris J J Mulder; Gerd Bouma
Journal:  Clin Transl Gastroenterol       Date:  2021-08-01       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.